Aytu BioPharma, Inc.AYTUNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank43
Studio
Year-over-Year Change

Return on equity

Latest
-71.51%
↑ 65% vs avg
Percentile
P43
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-205.77%
Historical baseline
PeriodValueYoY Change
2025-71.51%-25.1%
2024-57.17%-31.9%
2023-43.32%+82.4%
2022-245.51%-479.4%
2021-42.37%-195.6%
2020-14.34%+97.8%
2019-665.47%-776.9%
2018-75.89%+86.5%
2017-562.73%-101.4%
2016-279.42%-